期刊论文

Clinical observation of Fangcang No.3 Formula combined with Baduanjin in the treatment of 113 patients with light and common Corona Virus Disease 2019

中文

中华中医药杂志

1673-1727

2020

35

7

3742-3745

湖南省中医药防治新冠肺炎科研攻关项目（No.KYGG02）~~；

本校为第一机构

目的:观察方舱3号方配合八段锦对方舱医院2019冠状病毒病(COVID-19)轻型和普通型患者的临床疗效影响。方法:选取方舱医院收治的113例COVID-19轻型和普通型患者为研究对象,采用方舱3号方内服配合八段锦治疗,回顾性分析年龄、性别、临床表现、临床疗效及胸部CT、新型冠状病毒核酸检测转阴信息及转归情况。结果:113例患者中女性112例,男性1例,平均年龄(46.66±12.91)岁。临床表现以发热、咳嗽、胸闷、纳差、乏力、腹泻为主,治疗有效率93.14%(95/102),0例转重症。CT结果多显示吸收期改变,有效率86.87%(86/99)。新型冠状病毒核酸检测转阴时间平均为8.1d。治愈出院97例,转定点医院16例,平均住院时间(1...

Objective:To observe the clinical effects of Fangcang No.3 Formula combined with Baduanjin on patients with light and common Corona Virus Disease(COVID-19)in Fangcang hospital.Methods:A total of 113 patients with light and common COVID-19 from Fangcang hospital were selected and treated with Fangcang No.3 Formula combined with Baduanjin.Finally,the age,gender,clinical manifestations,clinical efficacy,chest CT,nucleic acid detection negative conversion rate and cure rate were retrospectively analyzed.Results:Among the 113 patients,112 were femal...